We show that CCN1/CYR61 signaling via α6β1, but not via αvβ3/αvβ5, drives an endocrine resistance phenotype that involves the unforeseen direct binding of CCN1 to ERα to regulate its transcriptional activity in breast cancer cells. Here, ESR1 is linked to breast carcinoma.